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Abstract 
 
We use Time-of-Flight Secondary Ion Mass Spectrometry (TOF-SIMS) to image and classify 
individual cells based on their characteristic mass spectra. Using statistical data reduction on the 
large data sets generated during TOF-SIMS analysis, similar biological materials can be differentiated 
based on a combination of small changes in protein expression, metabolic activity and cell structure. 
We apply this powerful technique to image and differentiate three carcinoma-derived human breast 
cancer cell lines (MCF-7, T47D and MDA-MB-231). In homogenized cells, we show the ability to 
differentiate the cell types as well as cellular compartments (cytosol, nuclear and membrane). These 
studies illustrate the capacity of TOF-SIMS to characterize individual cells by chemical composition, 
which could ultimately be applied to detect and identify single aberrant cells within a normal cell 
population.  Ultimately, we anticipate characterizing rare chemical changes that may provide clues to 
single cell progression within carcinogenic and metastatic pathways. 
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To distinguish cancerous cells from their normal counterparts, it is necessary to detect subtle 
chemical differences between cells. Traditionally, pre-cancerous and cancerous lesions have been 
identified histopathologically, based on recognizing specific, known patterns of disease progression.1 
More recently, characteristic patterns of gene expression measured by DNA microarrays as well as 
mass spectrometry of protein samples have been used to classify tumors into clinically relevant 
subgroups.2-11 These studies have demonstrated that no single change in protein or gene can 
adequately identify a cell or tissue that will become cancerous. Therefore, detection methods must be 
able to analyze and interpret a large number of variables that together suggest progression from 
normal.  At present, no method has been shown to both detect and image these types of changes in 
single cells. We are developing Time-of-Flight Secondary Ion Mass Spectrometry (TOF-SIMS) 
techniques to image and classify individual cells based on their characteristic mass spectra. 
TOF-SIMS is a highly sensitive surface analysis technique that can be used to detect the 
chemical composition of a biological sample and in the case of an individual cell, produce a mass-
spectral map of the spatial distribution of abundant ions at the sub-cellular level.  TOF-SIMS 
measurements use a finely focused (~150 nm) energetic primary ion beam to desorb secondary 
molecular and fragment ions into a time-of-flight mass spectrometer. Because the mass spectrum 
from each cell captures the mass signatures of both known and unknown molecules, no prior 
knowledge of the target analyte(s) is needed.  The technique has high spatial resolution and is highly 
sensitive; thousands of spectra can be measured from a 20 µm diameter mammalian cell and as little 
as 40 zeptomole (10-21 mole) of an analyte can be detected from the surface area of a typical 
eukaryotic cell.12 
Several groups have been successful in identifying intracellular distributions of specific 
biological ions such as sodium, potassium, calcium and membrane lipid fragments using TOF-SIMS 
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technology.13-22 In human breast cells exposed to the carcinogen PhIP, the target compound was 
found in detectable amounts within the outer leaflet membrane of the cells.  However, no carcinogen 
was found in the cytoplasm or nucleus, despite the known DNA-binding properties of the compound.12 
Similarly, analysis of yeast cells that had been exposed to the drug clofazimine demonstrated the 
presence of the drug within the cells, although not at the concentrations expected.19  Our approach in 
this work is not to use specific ions to characterize cells but rather the full complement of detectable 
ion fragments. 
The strength of the ToF-SIMS technique arises from the data generated; each image is 
composed of 256 x 256 individual spectra, which provide highly detailed chemical maps of the sample 
being analyzed.  However, the spectra of biological samples are extremely complex and difficult to 
interpret, due to the contribution of secondary ions that are generated from fragmentation of larger 
molecules within the sample and matrix effects that change the secondary ion yield depending on the 
chemical environment of the surface being sampled.23 Further, because most of a cell’s mass is 
comprised of proteins, which are composed of only 20 fairly homogenously distributed amino acids, 
there is a lack of unique peaks among different biological samples.  In fact, mass spectra obtained 
from different types of biological materials qualitatively appear very similar.  It is not possible by 
looking at a TOF-SIMS spectrum to select a subset of peaks that uniquely identify the sample from 
which the spectra are generated. Therefore, data reduction techniques must be used to analyze the 
large spectral data sets generated by TOF-SIMS to differentiate similar biological materials. 
Principal Component Analysis (PCA) has been used to identify similarities and differences in 
TOF-SIMS spectra and classify spectra into groups.23-25 PCA, a standard, unsupervised multivariate 
statistical technique, reduces a large data matrix to a few manageable variables that can be 
visualized and interpreted using a series of simple plots.  PCA reduces the data by finding new axes, 
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which represent linear combinations of the original data, called principal components (PCs) that 
capture the greatest variation in the data set.   The masses with the highest variance among the 
statistical groups are designated as responsible for the differences between samples.   
Wagner and Castner have used PCA and singular value decomposition to successfully cluster 
TOF-SIMS mass spectra generated from samples of single proteins and from samples of alkanethiol 
self-assembled monolayers, adsorbed onto gold substrates.23, 26-28 Statistical analysis of TOF-SIMS 
spectra has also been employed to distinguish three species of freeze-dried yeasts based on 
membrane phospholipids29 and to discriminate four yeast strains based on composite spectra from 
samples of yeast cultures.30 Vegetative Bacillis cells were discriminated from spores based on TOF-
SIMS analysis of phospholipid fragments.31 
In a unique application of TOF-SIMS to the problem of cancer cell differentiation, we 
demonstrate the ability to image and identify individual cells from three human breast cancer cell 
lines, MCF-7, T47D, and MDA-MB-231. These three cell lines represent well-established models of 
different breast cancer phenotypes; MCF-7 and T47D are estrogen receptor positive (ER+) 32, 33 and 
MDA-MB-231 is estrogen receptor negative (ER-).34 We also confirm the ability of TOF-SIMS and 
PCA to analyze and differentiate pure proteins and use the loadings plot generated by this analysis to 
give biological relevance to the separations. We show that PCA data reduction of TOF-SIMS spectra 
can differentiate cellular compartments (cytosol, nuclear and particulate) within the cell types.  We are 
also able to differentiate homogenates from among the three breast cancer cell lines. The technique 
described here could ultimately be applied to detect a single aberrant cell within a normal cell 
population and to characterize rare chemical changes that may provide clues to single cell 
progression within carcinogenic and metastatic pathways. 
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Experimental Section 
 
Amino Acid and Protein Analysis.  Twenty amino acids and seven proteins (albumin, cytochrome 
C, ferritin, hemoglobin, insulin, lysosyme, and myoglobin), were obtained from Sigma (St.Louis, MO).  
The standards were diluted in water to an approximate concentration of 1mg/ml, spotted on silicon 
(Si) wafers and allowed to evaporate at room temperature. The amino acid composition of each of the 
proteins was based on the downloaded sequences in FASTA format from the protein's PDB (Protein 
Data Bank) identification code. The code used for each protein was: 1PID---despentapeptide insulin, 
1A3N---Deoxy Human Hemoglobin, 1AEW---L-chain Horse apoferrin, 1AKK---Oxidized Horse Heart 
Cytochrome C, 1AO6---Human Serum Albumin and 1AZF---Chicken Egg White Lysozyme 
 
Cell Culture. MCF-7, T47D, and MDA-MB-231 human breast cancer cells were obtained from 
American Type Culture Collection (ATCC, Manassas, VA). MCF-7 cells were grown in DMEM 
(Dulbecco’s Modified Eagle Medium) with 5% fetal bovine serum (FBS), 1% non-essential amino 
acids, 10 µg/ml insulin, 2 mM L-glutamine, and 1% penicillin/streptomycin. T47D cells were grown in 
RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L 
glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate and supplemented with 0.2 units/ml bovine 
insulin, 1% penicillin/streptomycin and 10% FBS. MDA-MB-231 cells were grown in Leibovitz’s L-15 
medium with 2 mM L-glutamine, 1% penicillin/streptomycin and 10% FBS. All cells were maintained 
at 37°C with 5% CO2. All tissue culture supplies were obtained from Invitrogen (Carlsbad, CA).  
 For cell homogenization experiments, 2 x 106 cells were plated in T75 flasks and were 
harvested 48h later, when the cells were 75% confluent. For whole cell analysis, 8 x 105 cells were 
plated in a 60 mm dish containing 3 to 5 silicon chips, each about 1 cm square. The Si chips were 
sterilized by UV irradiation prior to seeding. Cells were grown on the polished side of the silicon chips; 
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no change was observed in cellular growth or morphology as compared to cells grown on the typical 
plastic-cell-culture ware.  Cells grown on chips were freeze-fractured 48 h after plating. 
 
Sample preparation.  For homogenate experiments, cell populations were washed twice with 5 ml 
phosphate buffered saline (PBS) before being scraped into 3 ml PBS and transferred to a centrifuge 
tube.  Centrifuging at 450 x g for five minutes pelleted the whole cells and the supernatant was 
discarded.  The pelleted cells were resuspended in 1 ml of hypotonic lysis buffer (10mM HEPES, pH 
7.9, 15mM MgCl2, 10mM KCl, 1mM dithiothreitol, and Sigma protease inhibitor cocktail P 8340) and 
incubated for 15 minutes to allow the cells to swell.  The cells were again pelleted by centrifugation, 
the supernatant discarded, and the pellet resuspended in 400 µl of lysis buffer.  The swollen cells 
were lysed by passing through a 27-gauge hypodermic needle five times and the resulting solution 
was then centrifuged at 11,000 x g for 20 minutes. Trypan blue exclusion was used to monitor cell 
lysis in a small aliquot of cells. The supernatant, which is the cytoplasmic fraction, was removed and 
placed on ice.  The pellet (nuclei and membranes) was then resuspended in 200 µl lysis buffer and 
shaken gently for 30 minutes.  The nuclei were disrupted by passing through a 27-gauge hypodermic 
needle five times and this solution was then centrifuged at 20,000 x g for five minutes. The 
supernatant (nuclear fraction) was then removed, placed on ice and the pellet (particulate fraction) 
was again resuspended in lysis buffer. Less than 1 µl of each homogenate fraction was spotted on a 
silicon chip using a micropette with disposable tips.  The samples were allowed to air dry and were 
stored at room temperature until TOF-SIMS analysis. Hypotonic buffer and mechanical disruption 
were used to lyse the cells because lysis with detergent buffers produces “sticky” spots that yield low 
ion counts in TOF-SIMS analysis. The experiment was repeated three times. 
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The samples for single cell analysis were prepared using a sandwich freeze-fracture method.35  
Approximately 10,000 latex beads (6 µm diameter, Duke Scientific Corp. (Palo Alto, CA)) in 10 µl 
PBS were added to the cells growing on Si chips immediately before sandwiching and fracturing.  The 
beads act as spacers between the chips. The chips with attached cells were sandwiched with a clean 
silicon piece and flash-frozen in liquid nitrogen-cooled isopentane for 1 minute. The frozen sandwich 
was transferred to a liquid-nitrogen-cooled metal block and snapped apart with a razor blade. The 
substrate side of the sandwich was kept frozen on dry ice and lyophilized overnight. The samples 
were stored in a desiccator at room temperature until analysis by TOF-SIMS. 
 
TOF-SIMS Analysis.  The TOF-SIMS measurements were conducted on a PHI TRIFT III instrument 
(Physical Electronics USA, Eden Prairie, MN) equipped with a gallium (69Ga+) liquid metal ion gun 
operated at 25kV.  A pulsed low-energy electron gun provided charge neutralization for all samples.  
Positive ion TOF-SIMS spectra were generally acquired over an area of 100 x 100 µm. The samples 
were held at room temperature during the course of the TOF-SIMS measurements.  All TOF-SIMS 
spectra were calibrated to the CH3+, C2H3+, and C4H7+ peaks before PCA analysis. Five to ten spectra 
were recorded for each amino acid, protein or cell homogenate spot.  For whole cell analysis, six or 
seven cells of each cell type showing the exclusion of sodium from the cellular area, which is 
evidence of fracturing an intact cell,35 were imaged and the average spectrum encompassing the 
whole cell was recorded.   
 
PCA analysis.   Unit mass binning was applied to each spectrum before further analysis.  For data 
reduction of the proteins, masses 50 to 500 of each TOF-SIMS spectrum were normalized to the total 
ion count of these masses for that spectrum.  For cell homogenates and individual cells, m/z = 69 
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(implanted gallium ions) and m/z = 73, 147, and 207 (PDMS contamination peaks) were removed 
from the data set and then masses 58 through 500 were normalized to the total ion count of these 
masses for each spectrum. All resulting data matrices were mean-centered and reduced by principal 
component analysis (PCA) using MATLAB software v. 7.0 (MathWorks Inc., Natick, MA) along with 
PLS Toolbox v. 3.5 (Eigenvector Research, Manson, WA).  The PCA software generates a scores 
plot to visualize data relationships and a loadings plot to determine masses important for sample 
differentiation. For the homogenate samples, m/z = 72, a strong fragment from the protease inhibitor, 
was removed from the data set for PCA analysis. Ninety percent confidence ellipses were drawn 
using the error_ellipse.m code by J. Andrew Johnson of Binghamton University, acquired from the 
MATLAB Central File Exchange.  
 
Results and Discussion 
TOF-SIMS analysis of pure protein standards 
To serve as a reference for interpreting the peaks important in the separation of the samples, 
mass spectra were taken from all 20 naturally occurring amino acids. Table 1 lists the molecular 
weight of each amino acid and the major or diagnostic fragments from the mass spectra.  As low 
mass fragments tend not to be chemically specific, only amino acid fragments with masses greater 
than 50 are presented.  The higher masses contain the unique amino acid fragments that we expect 
to be characteristic of a particular amino acid.  This analysis utilizing a Ga+ Liquid Metal Ion Gun 
(LMIG) compares well with earlier amino acid analyses by Wagner et al. using a Cs+ LMIG.26, 28  The 
advantage of the Ga+ LMIG is that molecular ion peaks are abundant and can be employed as 
diagnostic peaks in addition to the fragments identified by Wagner et al. 
 9 
To confirm the data reduction scheme that would eventually be used on individual cells, 
positive ion TOF-SIMS mass spectra from pure protein standards were reduced using PCA analysis. 
Seven proteins: albumin, cytochrome C, ferritin, hemoglobin, insulin, lysosyme, and myoglobin, were 
analyzed. The amino acid composition of each of the proteins used in the analysis, based on the 
sequences obtained from the PDB database is provided in Table 2. Figure 1A shows the PCA data 
reduction scores plot for the seven proteins. The numbers in parentheses on each axis are the 
percent of variance captured by that axis. In this plot, PC 1 and PC 2 capture over 74% of the 
variance of the data set. The TOF-SIMS mass spectra of the proteins are well separated as shown by 
the minimal overlap in the 90% confidence limit ellipses.   
The loadings plot, figure 1B, shows the masses that are important for separating the spectra of 
the proteins. By identifying the ions in the loading plot, we can demonstrate that the masses that 
represent the largest variance in the spectra are those that correlate to known properties of the 
proteins.  Iron (m/z = 56) clearly separates the proteins on PC1, from lowest to highest iron content.  
Ferritin, an iron storage protein that may contain up to 4500 iron atoms 36 is well separated from the 
remaining proteins on the positive side of PC1. Cytochrome C, myoglobin, and hemoglobin, which 
each contain the same iron-porphyrin prosthetic group (heme) that binds one iron atom,37 are further 
separated from lysosyme, albumin, and insulin, which contain no iron.  Clearly, iron content explains 
much of the observed differentiation of these proteins. 
A comparison of the ions identified in the loadings plot as responsible for the separation of the 
proteins to the ions found in the fragmentation of the pure amino acid standards (Table 1), suggests 
the identity of several of the ions important for the protein separation along PC2.  The ion at m/z = 72, 
which is predominant in the valine spectrum, is responsible for the separation of insulin, hemoglobin, 
and albumin from the other proteins.  Table 2 confirms that these proteins have the highest 
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percentage of valine residues.  Another ion that contributes to the separation on PC2 is m/z = 55, 
which is seen in both lysine and arginine spectra.  As shown in Table 2, Cytochrome C and 
myoglobin have the largest percentage of lysine residues and lysosyme has the largest percentage of 
arginine. The peaks at m/z = 57 (a common minor amino acid fragment), m/z = 110 (an ion seen in 
the histidine spectrum), m/z = 120 (an ion seen in the threonine and phenylalanine spectra), and m/z 
= 73 and 81, are also important for the protein separation. Thus, Figure 1 demonstrates that the TOF-
SIMS spectra from pure protein standards group well together.  Although the fragment ions from free 
amino acids could be different from the fragment ions from proteins, it appears that the differentiation 
of these proteins along PC2 can be explained by free amino acid fragments and subtle differences in 
the protein amino acid composition. 
Wagner et al. have also performed TOF-SIMS analysis of pure protein standards using a 
Cesium ion source.26, 28, 38  These studies showed grouping of the protein spectra and correlations to 
relevant amino acid fragments in the loadings plots using PCA analysis.  In addition, two other 
multivariate supervised methods, linear discriminant analysis (LDA) and discriminant principal 
component analysis (DPCA) were used for data reduction.38 The PCA method that we describe is 
identical to that used by Wagner et al., confirming their results. We have chosen to use PCA for our 
analyses because it is a well-accepted, straightforward multivariate analysis technique, and is 
sufficient for our purposes.  In addition, because PCA is an unsupervised technique, the samples are 
not identified in the analysis and there are no a priori assumptions as to the grouping of spectra.  
Therefore, spectral grouping and separation by PCA stems solely from the spectral data and is very 
robust.  For more complicated samples, it may be necessary to use a supervised data reduction 
technique to effect a sufficient separation. 
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 TOF-SIMS analysis of human breast cancer cell homogenates 
The initial analysis of the human cell lines was done on cell homogenates to ensure consistent 
access to the cell’s contents and to determine chemical characteristics of the intracellular 
compartments of the cell lines.  Low mass peaks (below m/z = 58) were removed from the PCA 
analysis to eliminate those peaks which are abundant and yet not chemically specific.  Figure 2A 
shows the scores plot of the first two principal component axes of the positive ion spectra taken from 
the cytosolic, nuclear and particulate fractions of the 3 human breast cancer cell lines. These 
groupings, which depict both the variance within the groups and the relationship among the groups, 
demonstrate the chemical similarities and differences of the various fractions within and among the 
cell types. In this analysis, PC1 and PC2 together capture more than 81% of the variation among data 
groups. The ellipses drawn around each group represent the 90% confidence limit for that group. The 
variation seen within the groups, which results in scattered data points and larger confidence ellipses, 
has several sources.  Some is instrument related; slight variation in TOF-SIMS spectra is found even 
during the analysis of homogenous solid surfaces. However, the major contribution to the variation 
comes from the samples themselves. Spots of cell homogenates are not uniform due to local protein 
aggregation and crystallization effects that occur as the liquid homogenates dry. 
In Figure 2A, PC 1 separates the particulate fractions from the cytosolic and nuclear fractions 
of each cell line. This suggests that the small molecules and fragments measured from the spots of 
the particulate fractions, which are composed of the insoluble membranes and structural proteins of 
the cell, are chemically distinguishable from the cytosolic and nuclear fractions. The spectra 
measured from the T47D particulate spot are highly variable, as evidenced by the spectral scatter 
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and the large 90% confidence oval for that group. This large variation may be a result of lack of 
uniformity of this sample.  
Although the particulate fractions of each of the cell types are well separated from the cytosolic 
and nuclear fractions along PC1, and the particulate fractions of the 2 ER+ cell lines (MCF7 and 
T47D) are well-separated from each other, the 90% confidence ovals for the particulate fractions of 
the MDA-MB-231 and T47D are overlapping. This could be due to the large variation seen in the 
T47D particulate spectra, or it may be that the membranes and structural proteins of these 2 cell lines 
are more chemically similar to each other than to the MCF-7 cells.   
Because the MDA-MB-231, MCF-7 and T47D cell lines are standard models for breast cancer 
mechanistic studies, they have been well-characterized in the literature using traditional biological 
assays. The ER- MDA-MB-231 cell line has been demonstrated to be a highly metastatic and 
tumorigenic39, 40 and is considered to express genes that represent a poor prognosis signature.41 In 
contrast, the ER+ MCF-7 and T47D lines are classified as non-invasive.42 Further, MCF-7 and T47D 
cells have been shown to express membranous E-cadherin and β-cadherin, which are powerful tumor 
suppressors.42, 43 MDA-MB-231 cells do not express these proteins in their surface membranes.42 
Based on just these cited studies, we would expect that the MCF-7 and T47D particulate fractions 
would be more similar to each other, and different from the MDA-MB-231. However, although these 
studies are important descriptions of the cancer phenotype of these cell lines, they report specific 
differences among the cell lines that may not necessarily reflect more global differences in cell 
structure.  In our analysis, we find that the cell types are well-separated, but the relationship of the 
groups does not correlate with the invasive potential of the cell line. This suggests that the differences 
among the cells that are important for TOF-SIMS analysis may not arise from specific, low abundant 
proteins discovered using traditional biological approaches.    
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Figure 2A also shows that the nuclear fractions of each cell type are primarily separated along 
PC2 and that these fractions are well separated from each other. Our cell homogenization protocol, 
produces nuclear fractions composed of small molecules, localized to the nucleus, and soluble 
nuclear proteins.  The scores plot suggests that the chemical composition of these small molecules 
and small molecular fragments is sufficient to chemically differentiate among the 3 human breast 
cancer cell types. 
 Both multivariate axes, PC1 and PC2, are necessary to differentiate the cytosolic fractions of 
the cell lines. Again, as seen in the particulate analysis, the cytosolic portions of the T47D and MDA-
MB-231 cells are slightly overlapping and more chemically similar to each other than to the cytosolic 
fractions of the MCF-7 cells. These groupings are also similar to the relationship we found among the 
nuclear fractions of cells.  Interestingly, of the three cell compartments that we investigated, the 
cytosolic fractions of the cell lines were the most closely related. This suggests that there is less 
chemical difference in the cytosols of the cell lines than in the other cell compartments. 
 For all 3 cell lines, the nuclear and cytosolic fractions are closely related and for the MCF-7, 
the nuclear and cytosolic fractions are overlapping. A further PCA analysis of just the MCF-7 and 
T47D homogenate spectra (removing the MDA-MB-231 spectra which have the largest within group 
variation) again showed cell line dependent differentiation of the cytosolic fractions (MCF-7 and T47D 
cytosols were separated from each other), but no differentiation of the MCF7 cytosol and nuclear 
fractions (data not shown). The close relationship between the cytosolic and nuclear fractions is not 
unexpected.  The centrifugation technique that we use to separate the cell compartments is 
essentially imprecise and it is likely that there are cytosolic cell components contaminating the 
nuclear fractions of the homogenates. 
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The loadings plot for the cell homogenates, Figure 2B, shows the mass peaks which are 
primarily responsible for the differentiation.  Most of these peaks are fragments of hydrocarbons and 
therefore cannot be related to specific biological molecules. Some of the important peaks can be 
found in the spectra of pure amino acids, such as m/z = 70, which is found in the spectra of glutamic 
acid, leucine, proline, arginine and asparagine, and m/z = 86, which is found in leucine and 
iosoleucine spectra.  Important peaks that are common in both the homogenate and whole cell 
analysis are marked with asterisks. 
In contrast to the loadings plot for the proteins (Figure 1B), which provided information about 
the biological meaning behind the separation of the protein standards, the loadings plot for the cell 
homogenates is difficult to interpret.  To date, little has been done to identify the small molecules or 
small molecular fragments that are important in biological samples. As can be seen from our results, 
these ions provide enough chemically specific information to differentiate specific cell types.  More 
studies, focused on identifying the important masses in the loadings plot, need to be done before we 
can understand the biology that drives the separation of the cell types and cell compartments.  
The results of the cell homogenate experiments were confirmed by successfully repeating the 
entire procedure three times over a course of 18 months.  The data discussed here are 
representative of the results of these experiments. In addition, we performed PCA analysis of just the 
spectra taken from a single cell line (MCF-7) during that time and showed that although there was an 
expected increase in spectral variation, the molecular signature of the cell line remained essentially 
intact (data not shown). Given that cell culture lines are well-known for biological “drift” with changing 
passage number and that our data reflect cell population variations in cell cycle stage and cell 
density, a consistent small molecular signature for a single cell line suggests that the underlying 
chemical composition of a cell may be relatively constant and may be unique to that cell.  Further, 
 15 
once defined, this chemical signature could be used in supervised statistical techniques as a basis for 
identifying individual cells within a mixed cell population. 
 
TOF-SIMS analysis of individual human breast cancer cells 
Based on the successful separation of the homogenates of the cell lines, we applied a similar 
analysis technique to individual cells, utilizing the imaging capability of the TOF-SIMS instrument. 
Figure 3 shows total ion images of freeze-fractured MCF-7, MDA-MB-231, and T47D cells. Typically, 
T47D and MCF-7 cells display an epithelial cell phenotype and MDA-MB-231 cells have a more 
elongated, fibroblastoid shape.  Although only one cell of each type is shown in Figure 3, under usual 
growth conditions these cell lines show tremendous morphological variation making them 
indistinguishable from each other using optical microscopy. 
Mass spectral images were taken of six or seven fractured cells of each cell line and a 
composite mass spectrum of the entire cellular region was used for PCA analysis. The scores plot in 
Figure 4A shows a good separation of the MCF-7, MDA-MB-231, and T47D cell spectra, confirming 
our ability to differentiate cell types.  TOF-SIMS spectra taken from the background region near each 
cell, and treated identically to the cell spectra, failed to separate into groups using PCA data reduction 
(data not shown).  
In contrast to the results of the homogenate data, the spectra acquired from whole T47D cells 
were more similar to the MCF-7 cells, and not as closely related to the MDA-MB-231 cells. In fact, in 
the scores plot of the whole cells, the ER+ MCF-7 and T47D cells, which have a similar non-invasive 
phenotype, are closely related and well separated from the ER-, highly metastatic MDA-MB-231 cells. 
These results suggest that although the relationship of the cell compartments to each other did not 
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reflect the invasive potential of the cells, a composite analysis of all the cell’s parts may provide better 
clues about the cancer phenotype. 
The loadings plot for the individual cells (Figure 4B) shows that many of the significant masses 
driving the separations are important in both the cell and cell homogenate experiments.  Of the ion 
peaks important in the differentiation, m/z = 184 results from the head group of phospholipids, and 
m/z = 70, 81, and 95 all appear in pure amino acid spectra suggesting they could have a protein 
origin. Again, as with the cell homogenate loadings plot, more work needs to be done to identify the 
origin of these small molecules. However, the large number of mass peaks common to the PCA 
separation of the cells and cell homogenates shows the expected consistency in TOF-SIMS-based 
cell differentiation.  
 
Conclusion 
A major advance in cancer biology in recent years has been the identification of thousands of 
proteins, genes, signaling molecules and their related pathways that are important for both normal 
and neoplastic cell growth.44 Careful studies comparing normal cellular function to paired transformed 
counterparts have shown that cancer is a complex disease involving myriad molecular and cellular 
changes. The overarching conclusion from these previous studies has been that there is no single 
genetic or protein expression change or modification that can explain the development of cancer; 
rather it is a spectrum of subtle changes that defines the carcinogenic process.45  Clearly, novel 
strategies must be developed to discover the global changes within individual cells that are 
mechanistically involved in cancer initiation and progression in order to develop detection, prevention 
and treatment strategies.  
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We have demonstrated the ability to differentiate 3 closely-related human breast cancer cell 
lines, MCF7, T47D, and MDA-MB-231, using PCA analysis of TOF-SIMS spectra acquired from 
individual cells.  Even though the low m/z peaks in TOF-SIMS spectra are usually of unknown parent 
chemical origin, statistical characterization of an ensemble of these peaks represents an innovative 
method of studying and differentiating cell types at a molecular level.  This study demonstrates the 
power of imaging mass spectrometry to discover differences among cells that may not be apparent 
using traditional methods. TOF-SIMS imaging is a discovery technology that can scan structural 
variations and functional changes in cells and provide molecular information about the genesis of 
cancer.  This information could lead scientists to new drug development targets, detection 
techniques, prognosis predictors, and prevention strategies. 
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Table 1. Amino acid molecular peak and six most abundant or diagnostic TOF-SIMS 
fragments in descending order. 
Amino acid MW 
Most 
abundant 
2nd  
 
3rd  
 
4th  
 
5th  
 
6th  
 
Alanine 89 90 112 134 179 57 81 
Arginine 174 70 55 175 57 59 73 
Asparagine 132 133 155 177 87 56 70 
Aspartic acid 133 134 155 219 279 57 88 
Cysteine 121 55 122 219 241 57 76 
Glutamic acid 147 175 148 70 102 84 130 
Glutamine 146 147 84 130 101 56 279 
Glycine 75 76 98 120 178 200 57 
Histidine 155 110 156 82 95 69 55 
Isoleucine 131 132 86 69 263 56 58 
Leucine 131 132 86 70 55 57 263 
Lysine 146 55 56 147 84 69 104 
Methionine 149 61 166 120 150 56 91 
Phenylalanine 165 166 120 91 51 103 77 
Proline 115 116 70 231 68 117 138 
Serine 105 106 128 60 57 91 116 
Threonine 119 120 56 74 116 239 57 
Tryptophan 204 130 159 188 117 205 143 
Tyrosine 181 182 136 107 116 165 123 
Valine 117 72 118 55 57 235 59 
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 Table 2. Amino acid percent composition of selected proteins. 
Amino acid 
Cytochrome 
C Insulin 
Hemoglobin 
all chains Lysozyme Myoglobin Albumin Ferritin 
Alanine 5.8 4.3 12.5 9.3 9.8 10.6 8.6 
Arginine 1.9 2.2 2.1 8.5 1.3 4.1 6.3 
Asparagine 4.8 6.5 3.5 10.9 1.3 2.9 3.4 
Aspartic Acid 2.9 0.0 5.2 5.4 5.2 6.2 6.9 
Cysteine 1.9 13.0 1.0 6.2 0.0 6.0 1.1 
Glutamic Acid 8.7 8.7 4.2 1.6 8.5 10.6 8.6 
Glutamine 2.9 6.5 1.4 2.3 3.9 3.4 6.3 
Glycine 11.5 8.7 7.0 9.3 9.8 2.1 6.3 
Histidine 2.9 4.3 6.6 0.8 7.2 2.7 3.4 
Isoleucine 5.8 2.2 0.0 4.7 5.9 1.4 2.3 
Leucine 5.8 13.0 12.5 6.2 11.1 10.4 15.5 
Lysine 18.3 0.0 7.7 4.7 12.4 10.1 5.2 
Methionine 1.9 0.0 1.0 1.6 1.3 1.0 1.7 
Phenylalanine 3.8 6.5 5.2 2.3 4.6 5.3 4.6 
Proline 3.8 0.0 4.9 1.6 2.6 4.1 1.7 
Serine 0.0 6.5 5.6 7.8 3.3 4.1 5.7 
Threonine 9.6 0.0 5.6 5.4 4.6 4.8 3.4 
Tryptophan 1.0 0.0 1.0 4.7 1.3 0.2 0.6 
Tyr (Y) 3.8 6.5 2.1 2.3 1.3 3.1 3.4 
Valine 2.9 10.9 10.8 4.7 4.6 7.0 4.6 
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 Figure Legends 
Figure 1. Scores plot (a) from PCA data reduction of TOF-SIMS positive ion spectra 
from proteins spotted on a silicon chip. Data points are multiple regions of interest from 
a single spot.  Ellipses are 90% confidence intervals. Loadings plot (b) showing masses 
responsible for separation of protein spots. 
 
Figure 2. Scores plot (a) from PCA data reduction of TOF-SIMS positive ion spectra 
from cultured human cell homogenates separated by centrifugation into cytosol, 
nuclear, and insoluble particulate fractions. Ellipses are 90% confidence intervals. 
Loadings plot (b) showing masses responsible for separation of homogenate spots. 
Asterisks designate loading peaks that are common to the homogenate and the whole 
cell analysis. 
 
Figure 3. Ion images of cultured human MCF-7, MDA-MB-231 and T47D cells. 
 
Figure 4. Scores plot (a) from PCA data reduction of TOF-SIMS positive ion spectra 
from freeze-fractured MCF-7, MDA-MB-231 and T47D cells.  Ellipses are 90% 
confidence intervals.   Loadings plot (b) showing masses responsible for separation of 
cells. Asterisks designate loading peaks that are common to the homogenate and the 
whole cell analysis. 
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